O
AMGN icon

OppenheimerFunds’s Amgen AMGN Stock Holding History

OppenheimerFunds’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$8.72M Buy
45,886
+33,365
+266% +$6.37M 0.01% 686
2018
Q4 		$2.44M Sell
12,521
-56,945
-82% -$11.1M ﹤0.01% 834
2018
Q3 		$14.4M Sell
69,466
-23,228
-25% -$4.58M 0.02% 661
2018
Q2 		$17.1M Sell
92,694
-71,317
-43% -$12.6M 0.02% 620
2018
Q1 		$28M Sell
164,011
-13,531
-8% -$2.48M 0.03% 476
2017
Q4 		$30.9M Sell
177,542
-1,818
-1% -$322K 0.04% 447
2017
Q3 		$33.4M Sell
179,360
-7,726
-4% -$1.37M 0.04% 410
2017
Q2 		$32.2M Sell
187,086
-338,423
-64% -$55M 0.04% 413
2017
Q1 		$86.2M Sell
525,509
-152,183
-22% -$25.3M 0.1% 210
2016
Q4 		$99.1M Sell
677,692
-300,233
-31% -$45.2M 0.13% 193
2016
Q3 		$163M Buy
977,925
+659,689
+207% +$112M 0.2% 134
2016
Q2 		$48.4M Sell
318,236
-34,756
-10% -$5.4M 0.06% 323
2016
Q1 		$52.9M Sell
352,992
-270,781
-43% -$40.2M 0.07% 297
2015
Q4 		$101M Sell
623,773
-107,569
-15% -$16.9M 0.13% 174
2015
Q3 		$101M Sell
731,342
-2,043
-0.3% -$322K 0.14% 182
2015
Q2 		$113M Sell
733,385
-46,437
-6% -$7.44M 0.13% 193
2015
Q1 		$125M Sell
779,822
-26,262
-3% -$4.14M 0.14% 189
2014
Q4 		$128M Buy
806,084
+104,754
+15% +$16.3M 0.14% 180
2014
Q3 		$98.5M Sell
701,330
-541,610
-44% -$70.7M 0.11% 210
2014
Q2 		$147M Sell
1,242,940
-981,610
-44% -$114M 0.16% 161
2014
Q1 		$274M Buy
2,224,550
+8,820
+0.4% +$1.07M 0.32% 80
2013
Q4 		$253M Buy
2,215,730
+192,740
+10% +$21.9M 0.31% 84
2013
Q3 		$226M Buy
2,022,990
+1,007,920
+99% +$109M 0.3% 94
2013
Q2 		$100M Buy
+1,015,070
New +$105M 0.14% 184

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OppenheimerFunds's AMGN Position: Q1 2019 in Review

OppenheimerFunds increased its Amgen (AMGN) stake by 266% in Q1 2019, buying an estimated $6.37M and bringing the position to 45,886 shares worth $8.72M. The position accounts for 0.01% of the portfolio, ranked #686.

OppenheimerFunds first reported a position in AMGN in Q2 2013 and has held it in 24 quarters since. The position peaked at $274M in Q1 2014. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • OppenheimerFunds held 45,886 shares of Amgen worth $8.72M as of Q1 2019.
  • OppenheimerFunds bought 33,365 Amgen shares in Q1 2019, an estimated $6.37M.
  • Amgen made up 0.01% of OppenheimerFunds's portfolio in Q1 2019, its #686 holding.
  • OppenheimerFunds first reported a position in Amgen in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Amgen position peaked at $274M in Q1 2014.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.